The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases-Reference-Cited by-同舟云学术

The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases

Published:2022-10 Issue:4 Volume:102 Page:922-925
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Cheng Franco Wing Tak^ORCID,Fan Min,Wong Carlos King Ho^ORCID,Chui Celine Sze Ling,Lai Francisco Tsz Tsun,Li Xue,Wan Eric Yuk Fai,Tang Sydney Chi Wai,Chan Esther Wai Yin,Wong Ian Chi Kei

Funder

Hospital Authority

Food and Health Bureau

Department of Health and Social Care

Innovation and Technology Commission

Publisher

Elsevier BV

Subject

Nephrology

Reference8 articles.

1. COVID-19 and chronic kidney disease: an updated overview of reviews;Jdiaa;J Nephrol,2022

2. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey;Tanriover;Lancet,2021

3. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong;McMenamin;Preprint,2022

4. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar;Chemaitelly;N Engl J Med,2021

5. Immunogenicity and safety of COVID-19 vaccines in patients receiving renal replacement therapy: a systematic review and meta-analysis;Ma;Front Med (Lausanne),2022

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China;Frontiers in Immunology;2024-05-31

2. Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19;Kidney International Reports;2024-05

3. How has research on the effectiveness and safety of COVID-19 vaccination been evaluated: a scope review with emphasis on CoronaVac;Frontiers in Public Health;2024-04-10

4. Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China;Frontiers in Immunology;2024-01-08

5. Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD;Clinical Journal of the American Society of Nephrology;2023-12-26